These data indicate the immunosuppressive function of invasive cancer cells specifically for CD8+ cell infiltration, despite increased immune recognition and localisation of CD8+ cells with DCIS epithelial cells. This evidence concerns the gene CD8A and ductal breast carcinoma in situ.